2007
DOI: 10.1016/j.athoracsur.2007.07.010
|View full text |Cite
|
Sign up to set email alerts
|

Combined Surgical and Endovascular Repair of Complex Aortic Pathologies With a New Hybrid Prosthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(32 citation statements)
references
References 20 publications
1
31
0
Order By: Relevance
“…Table 3 shows that, since the first surgical experience by Kato during the mid 1990s [4], different case series have been published, reporting good early and midterm results. Inhospital mortality seems to be improved in comparison to the conventional ET (6.4% vs 10.2%, respectively) [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55]. In a recent review published in 2008, FET has even been considered the standard treatment for extended aortic aneurysm as an alternative to conventional ET, as it allows for one-stage repair of combined aortic arch and proximal descending aortic aneurysm [60].…”
Section: Fet Techniquementioning
confidence: 95%
See 1 more Smart Citation
“…Table 3 shows that, since the first surgical experience by Kato during the mid 1990s [4], different case series have been published, reporting good early and midterm results. Inhospital mortality seems to be improved in comparison to the conventional ET (6.4% vs 10.2%, respectively) [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55]. In a recent review published in 2008, FET has even been considered the standard treatment for extended aortic aneurysm as an alternative to conventional ET, as it allows for one-stage repair of combined aortic arch and proximal descending aortic aneurysm [60].…”
Section: Fet Techniquementioning
confidence: 95%
“…The proximal non-stented part is used to fix the prosthesis to the distal aortic arch and to allow for reconstruction of the arch itself. Different prostheses have been developed, both 'homemade' [4,[40][41][42][43][44][45][46][47][48][49][50] and commercially available, such as the ChavanHaverich (Curative Medical Devices GmbH, Dresden, Germany) [51] and the E-vita open (JOTEC GmbH, Hechingen, Germany) [52][53][54]. Stent grafts already commercially available for treating descending and abdominal aorta pathology, such as the GoreTAG (W.L.…”
Section: Fet Techniquementioning
confidence: 99%
“…The E-vita Open, which is the only stent graft that is currently commercially marketed, has been reported to have a survival rate of 100% during the average follow-up period of 11 months, and no stent graft-related complications were observed in the reported studies. 6 In the present case, we used a newly developed stent graft, and observed an excellent patient response during the early postoperative period. However, a long-term follow-up is necessary, and we hope to experience more cases in order to obtain a better evaluation of the effectiveness and possible adverse effects of this device in the future.…”
Section: Discussionmentioning
confidence: 86%
“…[2][3][4] However, most grafts that are used for open stent implantation are currently self-produced stent grafts, and the E-vita Open (Jotec, Hechingen, Germany) is the only commercial graft that integrates a stent with a graft. 5,6 The experimental stent grafts (Ube CL-0201; Ube Medical, Tokyo, Japan) reported here are composed of a woven polyester graft and a nickel-titanium alloy stent, and have been used in clinical trials at four institutions in Japan (Osaka University, Hiroshima-City Asa General Hospital, Kishiwada Tokushukai Hospital, and Nihon University) beginning in 2008. We experienced a case in which a total arch replacement and an open stent implantation were performed using this new stent graft.…”
Section: Introductionmentioning
confidence: 99%
“…These findings underline the potential role of combined approaches such as the frozen elephant trunk procedure in order to treat the entire thoracic aortic disease to avoid late complications [13,14]. Ongoing evaluations of these approaches will confirm their broader use in the future or will put them into question [15,16].…”
Section: Commentmentioning
confidence: 91%